CJC-1295 + Ipamorelin is a two-component peptide formulation consisting of a growth hormonereleasing hormone (GHRH) analog (CJC-1295) and a selective ghrelin receptor agonist (Ipamorelin)
Key findings: Prescribing trends Using a subset of Truveta Data, Truveta Research identified people who were prescribed a GLP-1 RA between January 1, 2019 and March 31, 2026
GHK-Cu can support scalp and follicle health alongside minoxidil , not as a replacement
Key Takeaway: Since you no longer have a gallbladder, you are not at risk for the gallstones or gallbladder inflammation sometimes associated with rapid weight loss or GLP-1 therapy
On one side, a study showed that body weight and whole-body fat mass decreased with both treatments, but without difference between the two arms [58]
Maintain strict quality control over each production process, with COA available upon request